Maternal diabetes-mediated RORA suppression contributes to gastrointestinal symptoms in autism-like mouse offspring. 2022

Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
Department of Pediatrics, Affiliated Foshan Maternity & Child Healthcare Hospital, The Second School of Clinical Medicine of Southern Medical University, Foshan, 528000, People's Republic of China.

Retinoic acid-related orphan receptor alpha (RORA) has been reported to be suppressed in autistic patients and is associated with autism spectrum disorders (ASD), although the potential role and mechanism of RORA on gastrointestinal (GI) symptoms in ASD patients is still not reported. In this study, we aim to investigate the contribution of RORA to GI symptoms through a maternal diabetes-mediated autism-like mouse model. Male offspring of diabetic dams were treated with either superoxide dismutase (SOD) mimetic MnTBAP or RORA agonist SR1078, or were crossbred with intestine epithelial cells (IEC)-specific RORA knockout (RORA-/-) mouse. Gene expression, oxidative stress and inflammation were measured in brain tissues, peripheral blood mononuclear cells (PBMC) and IEC, and GI symptoms were evaluated. Our results showed that SOD mimetic MnTBAP completely, while RORA agonist SR1078 partly, reversed maternal diabetes-mediated oxidative stress and inflammation in the brain, PBMC and IEC, as well as GI symptoms, including intestine permeability and altered gut microbiota compositions. IEC-specific RORA deficiency either mimicked or worsened maternal diabetes-mediated GI symptoms as well as oxidative stress and inflammation in IEC, while there was little effect on maternal diabetes-mediated autism-like behaviors. We conclude that RORA suppression contributes to maternal diabetes-mediated GI symptoms in autism-like mouse offspring, this study provides a potential therapeutical target for maternal diabetes-mediated GI symptoms in offspring through RORA activation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067877 Autism Spectrum Disorder Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V) Autistic Spectrum Disorder,Autism Spectrum Disorders,Autistic Spectrum Disorders,Disorder, Autistic Spectrum
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001321 Autistic Disorder A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V) Autism, Infantile,Kanner's Syndrome,Autism,Autism, Early Infantile,Disorder, Autistic,Disorders, Autistic,Early Infantile Autism,Infantile Autism,Infantile Autism, Early,Kanner Syndrome,Kanners Syndrome
D013482 Superoxide Dismutase An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. Hemocuprein,Ag-Zn Superoxide Dismutase,Cobalt Superoxide Dismutase,Cu-Superoxide Dismutase,Erythrocuprein,Fe-Superoxide Dismutase,Fe-Zn Superoxide Dismutase,Iron Superoxide Dismutase,Manganese Superoxide Dismutase,Mn-SOD,Mn-Superoxide Dismutase,Ag Zn Superoxide Dismutase,Cu Superoxide Dismutase,Dismutase, Ag-Zn Superoxide,Dismutase, Cobalt Superoxide,Dismutase, Cu-Superoxide,Dismutase, Fe-Superoxide,Dismutase, Fe-Zn Superoxide,Dismutase, Iron Superoxide,Dismutase, Manganese Superoxide,Dismutase, Mn-Superoxide,Dismutase, Superoxide,Fe Superoxide Dismutase,Fe Zn Superoxide Dismutase,Mn SOD,Mn Superoxide Dismutase,Superoxide Dismutase, Ag-Zn,Superoxide Dismutase, Cobalt,Superoxide Dismutase, Fe-Zn,Superoxide Dismutase, Iron,Superoxide Dismutase, Manganese

Related Publications

Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
January 2022, Communications biology,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
September 2019, Nutritional neuroscience,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
January 2021, Frontiers in neuroscience,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
January 2022, Frontiers in endocrinology,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
July 2015, JAMA,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
July 2015, JAMA,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
April 2015, JAMA,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
February 2017, JAMA,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
April 2024, The Journal of nutritional biochemistry,
Li Xiao, and Min Wang, and Wanhua Zhang, and Yuan Song, and Jiaying Zeng, and Huilin Li, and Hong Yu, and Ling Li, and Pingming Gao, and Paul Yao
March 2024, Physiology & behavior,
Copied contents to your clipboard!